Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

ClinicalTrials.gov ID: NCT01713738

Public ClinicalTrials.gov record NCT01713738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label, Phase I/II Trial of Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)in Children and Adolescents

Study identification

NCT ID
NCT01713738
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Neufeld, Ellis J, MD, PhD
Individual
Enrollment
36 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
Nov 8, 2012

2003 – 2005

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
UCLA, Mattel Children's Hospital Los Angeles California 90095
Stanford University School of Medicine Palo Alto California 94305
University of California, San Francisco San Francisco California 94143
Emory University School of Medicine Atlanta Georgia 30322
Children's Hospital Boston Boston Massachusetts 02115
Van Eslander Cancer Center, St. John Hospital Detroit Michigan 48236
Weill Medical College at Cornell University New York New York 10021
Southwestern Medical Center at Dallas Dallas Texas 75390
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01713738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01713738 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →